168 results
8-K
EX-99.1
KURA
Kura Oncology Inc
30 Jan 24
Results of Operations and Financial Condition
7:08am
and projected timelines for ziftomenib, tipifarnib and KO-2806, plans regarding regulatory filings, our expectations regarding the relative benefits
8-K
h7umpw
30 Jan 24
Results of Operations and Financial Condition
7:08am
8-K
EX-10.2
icmxmz 3i
26 Jan 24
Kura Oncology Announces Oversubscribed
4:08pm
S-3ASR
EX-4.8
6vi9ppixaeincf9qdpy
2 Nov 23
Automatic shelf registration
4:39pm
S-3ASR
EX-4.12
dljtdvsn0 3x6y6abais
2 Nov 23
Automatic shelf registration
4:39pm
S-3ASR
EX-4.11
oicu598r 1qjl9p5h
2 Nov 23
Automatic shelf registration
4:39pm
S-3ASR
EX-4.13
g9qa1xbj39w d6yp
2 Nov 23
Automatic shelf registration
4:39pm
S-3ASR
pktoexx
2 Nov 23
Automatic shelf registration
4:39pm
8-K
EX-1.1
vkguq14c
14 Jun 23
Kura Oncology Announces Commencement of Public Offering of Common Stock and Pre-Funded Warrants
4:07pm
424B5
g8rwc
14 Jun 23
Prospectus supplement for primary offering
4:06pm
424B5
8pjpcmh cw
13 Jun 23
Prospectus supplement for primary offering
4:08pm